• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

花生四烯酸级联在 COVID-19 感染中的作用:综述。

Role of arachidonic cascade in COVID-19 infection: A review.

机构信息

Department of Pharmacy, Noakhali Science and Technology University, Noakhali 3814, Bangladesh.

Department of Pharmacy, Noakhali Science and Technology University, Noakhali 3814, Bangladesh.

出版信息

Prostaglandins Other Lipid Mediat. 2021 Jun;154:106539. doi: 10.1016/j.prostaglandins.2021.106539. Epub 2021 Feb 14.

DOI:10.1016/j.prostaglandins.2021.106539
PMID:33592322
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7882227/
Abstract

The World Health Organization has described the 2019 Coronavirus disease caused by an influenza-like virus called SARS-CoV-2 as a pandemic. Millions of people worldwide are already infected by this virus, and severe infection causes hyper inflammation, thus disrupting lung function, exacerbating breath difficulties, and death. Various inflammatory mediators bio-synthesized through the arachidonic acid pathway play roles in developing cytokine storms, injuring virus-infected cells. Since pro-inflammatory eicosanoids, including prostaglandins, and leukotrienes, are key brokers for physiological processes such as inflammation, fever, allergy, and pain but, their function in COVID-19 is not well defined. This study addresses eicosanoid's crucial role through the arachidonic pathway in inflammatory cascading and recommends using bioactive lipids, NSAIDs, steroids, cell phospholipase A2 (cPLA2) inhibitors, and specialized pro-resolving mediators (SPMs) to treat COVID-19 disease. The role of soluble epoxide hydrolase inhibitors (SEHIs) in promoting the activity of epoxyeicosatrienoic acids (EETs) and 17-hydroxide-docosahexaenoic acid (17-HDHA) is also discussed. Additional research that assesses the eicosanoid profile in COVID-19 patients or preclinical models generates novel insights into coronavirus-host interaction and inflammation regulation.

摘要

世界卫生组织将一种名为 SARS-CoV-2 的类似流感的病毒引起的 2019 年冠状病毒病描述为大流行。目前,全世界已有数百万人感染了这种病毒,严重的感染会导致过度炎症,从而破坏肺功能,加重呼吸困难,甚至导致死亡。通过花生四烯酸途径生物合成的各种炎症介质在细胞因子风暴的发展中发挥作用,从而损伤病毒感染的细胞。由于促炎类二十烷素(包括前列腺素和白三烯)是炎症、发热、过敏和疼痛等生理过程的关键介质,但它们在 COVID-19 中的功能尚未明确。本研究通过花生四烯酸途径探讨了类二十烷素在炎症级联反应中的关键作用,并建议使用生物活性脂质、非甾体抗炎药、类固醇、细胞磷酯酶 A2(cPLA2)抑制剂和特殊的促解决介质(SPM)来治疗 COVID-19 疾病。还讨论了可溶性环氧化物水解酶抑制剂(SEHIs)在促进环氧化物二十碳三烯酸(EETs)和 17-羟基二十二碳六烯酸(17-HDHA)活性方面的作用。评估 COVID-19 患者或临床前模型中类二十烷素谱的进一步研究为冠状病毒与宿主的相互作用和炎症调节提供了新的见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5abc/7882227/663ef33017ca/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5abc/7882227/af2fa3ff68d7/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5abc/7882227/d8d2d9e83ad0/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5abc/7882227/869a10c8bd9f/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5abc/7882227/663ef33017ca/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5abc/7882227/af2fa3ff68d7/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5abc/7882227/d8d2d9e83ad0/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5abc/7882227/869a10c8bd9f/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5abc/7882227/663ef33017ca/gr4_lrg.jpg

相似文献

1
Role of arachidonic cascade in COVID-19 infection: A review.花生四烯酸级联在 COVID-19 感染中的作用:综述。
Prostaglandins Other Lipid Mediat. 2021 Jun;154:106539. doi: 10.1016/j.prostaglandins.2021.106539. Epub 2021 Feb 14.
2
Inflammation resolution: a dual-pronged approach to averting cytokine storms in COVID-19?炎症消退:避免 COVID-19 中细胞因子风暴的双管齐下策略?
Cancer Metastasis Rev. 2020 Jun;39(2):337-340. doi: 10.1007/s10555-020-09889-4.
3
Eicosanoids: The Overlooked Storm in Coronavirus Disease 2019 (COVID-19)?类二十烷酸:2019 年冠状病毒病(COVID-19)中被忽视的风暴?
Am J Pathol. 2020 Sep;190(9):1782-1788. doi: 10.1016/j.ajpath.2020.06.010. Epub 2020 Jul 8.
4
Possibility of averting cytokine storm in SARS-COV 2 patients using specialized pro-resolving lipid mediators.利用特异性促解决脂质介质来避免 SARS-COV-2 患者的细胞因子风暴。
Biochem Pharmacol. 2023 Mar;209:115437. doi: 10.1016/j.bcp.2023.115437. Epub 2023 Jan 30.
5
Role of specialized pro-resolving lipid mediators and their receptors in virus infection: a promising therapeutic strategy for SARS-CoV-2 cytokine storm.专门的促解决脂质介质及其受体在病毒感染中的作用:SARS-CoV-2 细胞因子风暴的有前途的治疗策略。
Arch Pharm Res. 2021 Jan;44(1):84-98. doi: 10.1007/s12272-020-01299-y. Epub 2021 Jan 4.
6
Pro resolving inflammatory effects of the lipid mediators of omega 3 fatty acids and its implication in SARS COVID-19.解析ω-3 脂肪酸的脂类介质的抗炎作用及其在 SARS-CoV-2 中的意义。
Med Hypotheses. 2020 Dec;145:110340. doi: 10.1016/j.mehy.2020.110340. Epub 2020 Oct 8.
7
Acute severe SARS COVID-19 patients produce pro-resolving lipids mediators and eicosanoids.急性重症 SARS-CoV-2 患者可产生促解决脂质介质和类二十烷酸。
Eur Rev Med Pharmacol Sci. 2021 Nov;25(21):6782-6796. doi: 10.26355/eurrev_202111_27123.
8
Mast cells activated by SARS-CoV-2 release histamine which increases IL-1 levels causing cytokine storm and inflammatory reaction in COVID-19.SARS-CoV-2 激活的肥大细胞释放组织胺,增加白细胞介素-1 水平,导致 COVID-19 中的细胞因子风暴和炎症反应。
J Biol Regul Homeost Agents. 2020;34(5):1629-1632. doi: 10.23812/20-2EDIT.
9
The need for precision nutrition, genetic variation and resolution in Covid-19 patients.精准营养、遗传变异和新冠病毒患者分辨率的需求。
Mol Aspects Med. 2021 Feb;77:100943. doi: 10.1016/j.mam.2021.100943. Epub 2021 Jan 28.
10
Infectious Clones Produce SARS-CoV-2 That Causes Severe Pulmonary Disease in Infected K18-Human ACE2 Mice.传染性克隆产生的 SARS-CoV-2 可导致感染 K18-Human ACE2 小鼠发生严重肺部疾病。
mBio. 2021 Apr 20;12(2):e00819-21. doi: 10.1128/mBio.00819-21.

引用本文的文献

1
The impact of C heavy ion irradiation-induced cellular mutations on the replication of the foot-and-mouth disease virus and the role of Cbr3.碳重离子辐照诱导的细胞突变对口蹄疫病毒复制的影响及Cbr3的作用
Cell Mol Life Sci. 2025 Jun 28;82(1):261. doi: 10.1007/s00018-025-05628-6.
2
Polyunsaturated Fatty Acid Imbalance-A Contributor to SARS CoV-2 Disease Severity.多不饱和脂肪酸失衡——导致新冠病毒疾病严重程度的一个因素。
J Nutr Metab. 2025 Mar 24;2025:7075883. doi: 10.1155/jnme/7075883. eCollection 2025.
3
The Role of Inflammation in the Pathogenesis of Viral Respiratory Infections.

本文引用的文献

1
Methylprednisolone in adults hospitalized with COVID-19 pneumonia : An open-label randomized trial (GLUCOCOVID).COVID-19 肺炎住院成人患者中使用甲泼尼龙:一项开放标签随机试验(GLUCOCOVID)。
Wien Klin Wochenschr. 2021 Apr;133(7-8):303-311. doi: 10.1007/s00508-020-01805-8. Epub 2021 Feb 3.
2
Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19: A Meta-analysis.COVID-19 重症患者全身使用皮质类固醇与死亡率的关联:一项荟萃分析。
JAMA. 2020 Oct 6;324(13):1330-1341. doi: 10.1001/jama.2020.17023.
3
A Novel Strategy to Mitigate the Hyperinflammatory Response to COVID-19 by Targeting Leukotrienes.
炎症在病毒性呼吸道感染发病机制中的作用
Microorganisms. 2024 Dec 7;12(12):2526. doi: 10.3390/microorganisms12122526.
4
Metabolomic Insights into COVID-19 Severity: A Scoping Review.对新冠病毒疾病严重程度的代谢组学见解:一项范围综述
Metabolites. 2024 Nov 12;14(11):617. doi: 10.3390/metabo14110617.
5
Contributing to the management of viral infections through simple immunosensing of the arachidonic acid serum level.通过简单检测血清花生四烯酸水平来辅助病毒性感染的管理。
Mikrochim Acta. 2024 Jun 4;191(7):369. doi: 10.1007/s00604-024-06440-y.
6
The Human Phospholipase B-II Precursor (HPLBII-P) in Urine as a Novel Biomarker of Glomerular Activity in COVID-19 and Diabetes Mellitus.尿液中的人磷脂酶B-II前体(HPLBII-P)作为COVID-19和糖尿病中肾小球活性的新型生物标志物。
J Clin Med. 2024 Apr 26;13(9):2540. doi: 10.3390/jcm13092540.
7
MetaboAnalystR 4.0: a unified LC-MS workflow for global metabolomics.MetaboAnalystR 4.0:一个用于全局代谢组学的统一 LC-MS 工作流程。
Nat Commun. 2024 May 1;15(1):3675. doi: 10.1038/s41467-024-48009-6.
8
1-L Transcription of SARS-CoV-2 Spike Protein S1 Subunit.严重急性呼吸综合征冠状病毒2刺突蛋白S1亚基的1-L转录
Int J Mol Sci. 2024 Apr 18;25(8):4440. doi: 10.3390/ijms25084440.
9
Targeting host-specific metabolic pathways-opportunities and challenges for anti-infective therapy.靶向宿主特异性代谢途径——抗感染治疗的机遇与挑战
Front Mol Biosci. 2024 Feb 22;11:1338567. doi: 10.3389/fmolb.2024.1338567. eCollection 2024.
10
Preliminary Comparison of Molecular Antioxidant and Inflammatory Mechanisms Determined in the Peripheral Blood Granulocytes of COVID-19 Patients.新冠肺炎患者外周血粒细胞中分子抗氧化和炎症机制的初步比较。
Int J Mol Sci. 2023 Sep 1;24(17):13574. doi: 10.3390/ijms241713574.
一种通过靶向白三烯减轻对COVID-19过度炎症反应的新策略。
Front Pharmacol. 2020 Aug 6;11:1214. doi: 10.3389/fphar.2020.01214. eCollection 2020.
4
Immune mechanisms of pulmonary intravascular coagulopathy in COVID-19 pneumonia.新型冠状病毒肺炎肺血管内凝血病变的免疫机制
Lancet Rheumatol. 2020 Jul;2(7):e437-e445. doi: 10.1016/S2665-9913(20)30121-1. Epub 2020 May 7.
5
Dexamethasone nanomedicines for COVID-19.用于治疗新冠肺炎的地塞米松纳米药物。
Nat Nanotechnol. 2020 Aug;15(8):622-624. doi: 10.1038/s41565-020-0752-z.
6
SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19.SARS-CoV-2 反应性 T 细胞在健康供体和 COVID-19 患者中的研究。
Nature. 2020 Nov;587(7833):270-274. doi: 10.1038/s41586-020-2598-9. Epub 2020 Jul 29.
7
Dexamethasone in Hospitalized Patients with Covid-19.地塞米松在 COVID-19 住院患者中的应用。
N Engl J Med. 2021 Feb 25;384(8):693-704. doi: 10.1056/NEJMoa2021436. Epub 2020 Jul 17.
8
Inflammation, Immunity and Immunogenetics in COVID-19: A Narrative Review.2019冠状病毒病中的炎症、免疫与免疫遗传学:一篇综述
Indian J Clin Biochem. 2020 Jul;35(3):260-273. doi: 10.1007/s12291-020-00897-3. Epub 2020 Jun 6.
9
What about COVID-19 and arachidonic acid pathway?那么 COVID-19 和花生四烯酸途径呢?
Eur J Clin Pharmacol. 2020 Nov;76(11):1501-1504. doi: 10.1007/s00228-020-02941-w. Epub 2020 Jun 25.
10
Re-analysis of SARS-CoV-2-infected host cell proteomics time-course data by impact pathway analysis and network analysis: a potential link with inflammatory response.通过影响途径分析和网络分析对感染SARS-CoV-2的宿主细胞蛋白质组学时间进程数据进行重新分析:与炎症反应的潜在联系。
Aging (Albany NY). 2020 Jun 23;12(12):11277-11286. doi: 10.18632/aging.103524.